Tang W - Search Results

1

An Aptamer-Modified DNA Tetrahedron-Based Nanogel for Combined Chemo/Gene Therapy of Multidrug-Resistant Tumors.

Tang W, Han L, Duan S, Lu X, Wang Y, Wu X, Liu J, Ding B. Tang W, et al. ACS Appl Bio Mater. 2021 Oct 18;4(10):7701-7707. doi: 10.1021/acsabm.1c00933. Epub 2021 Oct 4. ACS Appl Bio Mater. 2021. PMID: 35006686

2

A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy.

Tang W, Han L, Lu X, Wang Z, Liu F, Li Y, Liu S, Liu S, Tian R, Liu J, Ding B. Tang W, et al. ACS Appl Mater Interfaces. 2021 May 12;13(18):20974-20981. doi: 10.1021/acsami.1c02122. Epub 2021 Apr 28. ACS Appl Mater Interfaces. 2021. PMID: 33909408

3

Chemically modified DNA nanostructures for drug delivery.

Wang Y, Lu X, Wu X, Li Y, Tang W, Yang C, Liu J, Ding B. Wang Y, et al. Among authors: tang w. Innovation (Camb). 2022 Feb 10;3(2):100217. doi: 10.1016/j.xinn.2022.100217. eCollection 2022 Mar 29. Innovation (Camb). 2022. PMID: 35243471 Free PMC article. Review.

4

A DNA Origami-Based Gene Editing System for Efficient Gene Therapy in Vivo.

Tang W, Tong T, Wang H, Lu X, Yang C, Wu Y, Wang Y, Liu J, Ding B. Tang W, et al. Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202315093. doi: 10.1002/anie.202315093. Epub 2023 Nov 14. Angew Chem Int Ed Engl. 2023. PMID: 37906116

5

Chemically Conjugated Branched Staples for Super-DNA Origami.

Wang Y, Wang H, Li Y, Yang C, Tang Y, Lu X, Fan J, Tang W, Shang Y, Yan H, Liu J, Ding B. Wang Y, et al. Among authors: tang w, tang y. J Am Chem Soc. 2024 Feb 14;146(6):4178-4186. doi: 10.1021/jacs.3c13331. Epub 2024 Feb 1. J Am Chem Soc. 2024. PMID: 38301245

6

Preparation of single-stranded phagemid DNA without chromosomal DNA contamination.

Tang W, Liu JN, Gurewich V. Tang W, et al. Biotechniques. 1996 Jul;21(1):53-4. doi: 10.2144/96211bm10. Biotechniques. 1996. PMID: 8816234 Free article. No abstract available.

7

An efficient system for production of recombinant urokinase-type plasminogen activator.

Tang W, Sun ZY, Pannell R, Gurewich V, Liu JN. Tang W, et al. Protein Expr Purif. 1997 Dec;11(3):279-83. doi: 10.1006/prep.1997.0800. Protein Expr Purif. 1997. PMID: 9425632

8

Socio-economic factors affecting the success of tuberculosis treatment in six counties of Shandong Province, China.

Xu L, Gai R, Wang X, Liu Z, Cheng J, Zhou C, Liu J, Zhang H, Li H, Tang W. Xu L, et al. Among authors: tang w. Int J Tuberc Lung Dis. 2010 Apr;14(4):440-6. Int J Tuberc Lung Dis. 2010. PMID: 20202302

9

A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.

Liu JN, Tang W, Sun ZY, Kung W, Pannell R, Sarmientos P, Gurewich V. Liu JN, et al. Among authors: tang w. Biochemistry. 1996 Nov 12;35(45):14070-6. doi: 10.1021/bi9605393. Biochemistry. 1996. PMID: 8916892

10

Identification of a flexible loop region (297-313) of urokinase-type plasminogen activator, which helps determine its catalytic activity.

Sun Z, Jiang Y, Ma Z, Wu H, Liu BF, Xue Y, Tang W, Chen Y, Li C, Zhu D, Gurewich V, Liu JN. Sun Z, et al. Among authors: tang w. J Biol Chem. 1997 Sep 19;272(38):23818-23. doi: 10.1074/jbc.272.38.23818. J Biol Chem. 1997. PMID: 9295329 Free article.

This was related to the loop allowing the positive charge of Lys300(c143) to transiently interact with Asp355(c194), thereby inducing an active conformation of the protease domain (Liu, J. N., Tang, W., Sun, Z., Kung, W., Pannell, R., Sarmientos, P., and Gure …

This was related to the loop allowing the positive charge of Lys300(c143) to transiently interact with Asp355(c194), thereby inducing an act …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,044 results

Search Page